Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population

J. Yang (Glagow, United Kingdom), J. Busby (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom), P. Pfeffer (London, United Kingdom), D. Jackson (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), S. Siddiqui (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), R. Niven (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), N. Thomson (Glasgow, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom)

Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Session: Severe asthma phenotypes and outcomes
Session type: Oral Presentation
Number: 5039
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Yang (Glagow, United Kingdom), J. Busby (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom), P. Pfeffer (London, United Kingdom), D. Jackson (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), S. Siddiqui (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), R. Niven (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), N. Thomson (Glasgow, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom). Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population. 5039

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019



Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005


Effect of corticosteroids on lymphocytes from severe asthma patients
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Year: 2018


Effect of different asthma treatments on risk of cold-related exacerbations
Source: Eur Respir J 2011; 38: 584-593
Year: 2011



Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
Year: 2021



Factors associated with frequent exacerbations in patients with severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 369s
Year: 2001

Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019

Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005

The effects of inhaled corticosteroids on risk of self-reported osteoporosis and fractures in adult subjects with asthma
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017


Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007

The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


Oral corticosteroids-related comorbidities in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021

Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009